Biotech · Private company
Eiger BioPharmaceuticals
Track this companyFree. Adds Eiger BioPharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials100 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- LonafarnibPhase 3 · Hepatitis Delta VirusClinicalTrials.gov · fetched Nov 12, 2026
- PEG IFN-alfa-2aPhase 3 · Hepatitis Delta VirusClinicalTrials.gov · fetched Nov 12, 2026
- Peginterferon Lambda-1aPhase 3 · Hepatitis Delta VirusClinicalTrials.gov · fetched Nov 12, 2026
- RitonavirPhase 3 · Hepatitis Delta VirusClinicalTrials.gov · fetched Nov 12, 2026
- exendin 9-39Phase 2 · Postbariatric HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- ubenimexPhase 2 · LymphedemaClinicalTrials.gov · fetched Nov 12, 2026
- ubenimexPhase 2 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDVPHASE3 · UNKNOWN · started Dec 21, 2021ClinicalTrials.gov NCT05070364 · fetched Nov 12, 2026
- Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic HypoglycemiaPHASE2 · COMPLETED · started Jun 21, 2021ClinicalTrials.gov NCT04652479 · fetched Nov 12, 2026
- Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) InfectionPHASE2 · TERMINATED · started Jun 29, 2020ClinicalTrials.gov NCT04344600 · fetched Nov 12, 2026
- Pegylated Interferon Lambda Treatment for COVID-19PHASE2 · TERMINATED · started Jun 22, 2020ClinicalTrials.gov NCT04343976 · fetched Nov 12, 2026
- Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2aPHASE3 · COMPLETED · started Dec 1, 2018ClinicalTrials.gov NCT03719313 · fetched Nov 12, 2026
- Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric HypoglycemiaPHASE2 · COMPLETED · started Mar 19, 2018ClinicalTrials.gov NCT03373435 · fetched Nov 12, 2026
- Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)PHASE2 · TERMINATED · started Dec 1, 2016ClinicalTrials.gov NCT02736149 · fetched Nov 12, 2026
- Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA)PHASE2 · COMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT02700529 · fetched Nov 12, 2026
- A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)PHASE2 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02664558 · fetched Nov 12, 2026
- Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With ProgeriaPHASE2 · UNKNOWN · started Aug 1, 2009ClinicalTrials.gov NCT00916747 · fetched Nov 12, 2026